Last reviewed · How we verify
NCT01099488
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays
NA trial testing Blood withdrawal in Immunologic Tests in 46 participants. Completed in 7 December 2010.
7 December 2010
Quick facts
| Lead sponsor | GlaxoSmithKline |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 46 |
| Start date | 1 April 2010 |
| Primary completion | 7 December 2010 |
| Estimated completion | 7 December 2010 |
| Sites | 2 locations across Belgium |
Drugs / interventions tested
- Blood withdrawal — full drug profile →
Conditions studied
- Immunologic Tests — all drugs for Immunologic Tests →
Sponsor
GlaxoSmithKline — full company profile →
Who can join
Adults 18 to 50, any sex, with Immunologic Tests. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to develop immunological assays on blood samples.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01099488
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood withdrawal
Trials testing the same drug.
- NCT06113705 — Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. · NA · recruiting
- NCT06847100 — Artificial Intelligence Models to Predict Clinically Relevant Cardiovascular Outcomes · completed
- NCT05539183 — Collection of Pleural Effusion Fluid · NA · unknown
- NCT05510596 — Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome · NA · completed
- NCT05754645 — The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes · recruiting
Other GlaxoSmithKline trials
Trials by the same sponsor.
- NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam · Phase 2, PHASE3 · not yet recruiting
- NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose · Phase 1 · not yet recruiting
- NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
- NCT07286331 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-E · Phase 3 · not yet recruiting
- NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01099488 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
- Last refreshed: 27 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01099488.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing